Sartorius has closed the first nine months of 2012 with gains in order intake, sales revenue and earnings, leading to the management upgrading its forecast for full-year earnings.
Earnings at the company rose by 22.7 per cent to €100m (£80m), while sales revenues were up 18.1 per cent year over year to €639.4m. Order intake rose 15.8 per cent.
The bioprocess solutions division, which specialises in single-use products for pharmaceutical drug manufacture, performed well, according to the company.
In addition, initial consolidation of the Biohit Liquid Handling business boosted growth for the laboratory products and services division.